Le Vu, Abu-Fadel Mazen, Hennebry Thomas A
Department of Internal Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA.
Catheter Cardiovasc Interv. 2008 Nov 1;72(5):643-6. doi: 10.1002/ccd.21740.
The usage of tapered self-expanding stents and embolic protection devices in the treatment of stenotic ectatic coronary arteries.
Coronary artery ectasia (CAE) is an uncommon disease that is occasionally found during cardiac catheterization. A high incidence of artherosclerotic disease is associated with CAE. Currently, there is no evidence-based approach for the management of stenotic ectatic coronary arteries (SEC).
Percutaneous intervention with carotid stenting system and embolic protection system to recanalize SEC.
We describe two patients who presented with acute coronary syndrome and were found to have CAE with significant stenosis. Both patients underwent percutaneous intervention with RX ACCULINK Carotid stenting system and ACCUNET embolic protection system (Abbott Laboratories, Abbott Park, IL), successfully. This carotid stenting system is approved by FDA for stenting of extracranial carotid artery stenosis.
To the best of our knowledge, this is the first case report illustrating the usage of these devices as an alternative for the treatment of SEC.
锥形自膨式支架和栓子保护装置在治疗狭窄扩张型冠状动脉中的应用。
冠状动脉扩张（CAE）是一种罕见疾病，偶尔在心脏导管插入术中发现。动脉粥样硬化疾病的高发病率与CAE相关。目前，对于狭窄扩张型冠状动脉（SEC）的管理尚无循证方法。
采用颈动脉支架系统和栓子保护系统进行经皮介入以再通SEC。
我们描述了两名表现为急性冠状动脉综合征且被发现患有伴有明显狭窄的CAE患者。两名患者均成功接受了使用RX ACCULINK颈动脉支架系统和ACCUNET栓子保护系统（雅培实验室，伊利诺伊州雅培公园）的经皮介入治疗。该颈动脉支架系统已获美国食品药品监督管理局批准用于颅外颈动脉狭窄的支架置入。
据我们所知，这是首例说明使用这些装置作为SEC治疗替代方法的病例报告。
